Skip to content

Coaching-supported vs medication-only

Gala vs He & She MD: Coaching Included, or Just a Script? (2026)

Compare Gala and He & She MD on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.

Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.0 out of 10

We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.

Two platforms, one drug class, and a difference in annual cost most people do not notice until month four. That is the Gala versus He & She MD question.

The real difference is what happens between refills. He & She MD puts coaching app with 1:1 clinician messaging and progress tracking, no extra charge inside the monthly price; Gala leaves that to you and charges accordingly.

What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Undisclosed pricing is treated as a finding, not rounded into an estimate.

The short answer

Lowest 12-month cost
He & She MD$1,980 against $2,148 at Gala, on each provider's own best published pricing.
Most support for the money
GalaProvider check-ins and dose monitoring included.
Tirzepatide access
He & She MDTirzepatide at $199/mo; the other side publishes semaglutide only.
Most support included
GalaProvider check-ins and dose monitoring included.

Side-by-side comparison

Every figure below is the provider's own published number. The blank spaces are theirs, not ours.

 GalaHe & She MD
Advertised priceFrom $249/mo, as low as $179/mo on longer plansSemaglutide from $139/mo, oral semaglutide and tirzepatide from $199/mo
Rate after promotions$249/mo$191/mo
Pricing structureCheaper per month the longer you commitIntroductory term, then renewal at a higher rate
MedicationCompounded semaglutide and compounded tirzepatideCompounded semaglutide injection, oral semaglutide and compounded tirzepatide injection
Support modelProvider check-ins includedCoaching built into the plan
State coverageNot publishedNot published
How fast you startFully online, no in-office visits2-3 minute intake with no payment required to check eligibility
Membership feeNoneNone
Payment optionsCard only, no financing publishedCard only, no financing published
Patient reviews2,8704,180
eRxDoctor score7.7/107.0/10

Gala vs He & She MD on total cost, not entry price

Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. These are the totals — six months and twelve — using each provider's own published rates and best available plan.

 GalaHe & She MD
First month$249$139
Months 2 onward$249/mo$191/mo
6-month total$1,494$834
12-month total$2,988$1,980
Best published planlonger-term plan at $179/mo — $2,148/yrNo multi-month discount published

Over a year that is a $168 difference, in He & She MD's favor. Whether it is the right call depends on whether Gala gives you $14 a month of something you will use.

Price escalation to plan for: He & She MD moves from $139 to $191, a 37% increase. Set a calendar reminder for the month it changes.

Coaching, or just the prescription

He & She MD includes coaching app with 1:1 clinician messaging and progress tracking, no extra charge. That is a real cost to deliver, and it is priced into the monthly rate whether or not you open the app.

Gala is built the other way: provider check-ins and dose monitoring included. The medication does the pharmacological work, and everything around it is yours to organize.

Coaching is the line item people cancel first and miss most. Be honest about which patient you are before optimizing it away.

Gala in detail

Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery. Against He & She MD, that puts it in the position of the more expensive option.

Intake is fully online, no in-office visits. Fulfillment is home delivery. The commercial terms are cheaper per month the longer you commit, published upfront.

Behind the prescription sits provider check-ins and dose monitoring included. Available medication: compounded semaglutide and compounded tirzepatide.

Gala pros

  • Provider check-ins and dose monitoring included
  • Direct-pay model, no insurance or prior authorizations needed
  • Fully online, no in-office visits required

Gala cons

  • Higher entry price than several compounded competitors
  • Lower long-term pricing requires a multi-month commitment

Set beside He & She MD, the thing to weigh: the entry price sits above most compounded competitors unless you commit to a longer term.

How He & She MD works

He & She MD bundles compounded GLP-1 medication with a coaching app that carries 1:1 clinician messaging, GLP-1-specific guidance and progress tracking. Semaglutide injections start at $139/month, oral semaglutide and tirzepatide at $199/month, each a six-month introductory rate. Free expedited shipping, no membership fee, no insurance required. What it is really selling here is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO.

Practically: 2-3 minute intake with no payment required to check eligibility, free expedited shipping with no upcharges, and a pricing model that is introductory term, then renewal at a higher rate.

On the clinical side, coaching app with 1:1 clinician messaging and progress tracking, no extra charge, prescribing compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection.

He & She MD pros

  • Free expedited shipping on every order, with no shipping upcharges
  • No membership fee stacked on top of the medication price
  • Fast 2-3 minute intake with no payment required to check eligibility
  • Coaching app, 1:1 clinician messaging and progress tracking included at no extra cost

He & She MD cons

  • Pricing is structured as six-month terms, not true month-to-month
  • Headline prices are 6-month intro rates that renew 30-45% higher
  • The 15-25 lbs in 12 weeks figure is self-reported retrospective data, not trial data

Where it gives ground to Gala: the headline rates are six-month terms that renew 30-45% higher.

Who each program is actually built for

Choose Gala if:

  • delivery works the way you want it to: home delivery
  • the level of clinical contact suits you: provider check-ins and dose monitoring included
  • you want to start on their timeline: fully online, no in-office visits
  • you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)

Choose He & She MD if:

  • you want coaching app with 1:1 clinician messaging and progress tracking, no extra charge rather than a prescription alone
  • the twelve-month total is what you are optimizing ($1,980 against $2,988)
  • the monthly rate is the constraint — $191/mo against $249/mo
  • you want tirzepatide available without changing provider later

The trade-offs, stated plainly

On price. The monthly gap is 30% in He & She MD's favor. Whether that is a saving or a false economy turns on one thing: the headline rates are six-month terms that renew 30-45% higher.

On commitment. Gala rewards a longer commitment (longer-term plan at $179/mo), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.

On predictability. Cheaper per month the longer you commit at Gala, against introductory term, then renewal at a higher rate at He & She MD. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.

On access. Gala advertises fully online, no in-office visits and home delivery; He & She MD advertises 2-3 minute intake with no payment required to check eligibility and free expedited shipping with no upcharges. Neither publishes its state coverage, so confirm you are eligible before paying for anything.

What the evidence actually says

Weight loss percentages quoted in telehealth marketing come from trials neither Gala nor He & She MD ran. Here is the source material, and what regulators say alongside it.

The FDA approved tirzepatide for chronic weight management in November 2023, two years after semaglutide, per FDA.

In the STEP 1 trial, weekly semaglutide 2.4 mg produced a mean body-weight change of −14.9% at 68 weeks against −2.4% on placebo, per NEJM, STEP 1.

Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.

Gala vs He & She MD: common questions

Which costs less over a year, Gala or He & She MD?

He & She MD, at roughly $1,980 for twelve months against $2,148 at Gala, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.

Is He & She MD cheaper than Gala?

Yes, on the ongoing rate. He & She MD runs $191/mo once promotional pricing ends, against $249/mo at Gala — a difference of 30%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.

Do Gala or He & She MD take insurance?

Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.

Which has more patient reviews, Gala or He & She MD?

He & She MD, with 4,180 against 2,870. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.

Is coaching included with Gala or He & She MD?

He & She MD includes coaching app with 1:1 clinician messaging and progress tracking, no extra charge in the monthly price. Gala provides provider check-ins and dose monitoring included, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.

The verdict

Strictly on cost, He & She MD takes it — $1,980 to $2,148 over twelve months.

Gala earns the difference in one situation: when a direct-pay model with dose monitoring included rather than sold as an add-on is something you will genuinely use. If you cannot say that out loud, take the cheaper program.

Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.

Keep comparing

See every provider in context on the weight loss rankings, or browse the full comparison index.

Disclaimers and methodology

Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.

Some links are affiliate links and may generate commission at no extra cost to you.

Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.

eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or He & She MD, and does not sell treatment. Read our ranking methodology.